US case analysis: Myriad at the Supreme Court

Managing IP Correspondent

August 31 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Managing IP Correspondent

more from across site and SHARED ros bottom lb

More from across our site

Patents

This week on MIP: Nokia and Hisense sign deal | Bayer sues vaccine makers

News of Health Hoglund joining Sisvel and the Delhi High Court staying a $2.2 million decree in favour of Philips were also among the top talking points

Max Walters, January 09 2026

Patents

Magnifying glass emphasizing one glowing figure among group symbolizing focused hiring

Morgan Lewis nabs Ropes & Gray ITC expert

The firm is continuing its aggressive IP hiring streak with the addition of partner Matthew Rizzolo

Sanjana Mishra, January 08 2026

Patents

How Pantech convinced a Tokyo court of Google’s FRAND obligations

Pantech counsel Shogo Matsunaga speaks exclusively to Managing IP about how his team proved Google’s unwillingness, and ultimately secured a landmark SEP settlement

Sukanya Sarkar, January 08 2026

Trademarks

Exclusive: Brandsmiths adds two partners in bid to sharpen client focus

New partners, including the firm’s first female head of a department, are eyeing a deeper focus on client understanding

Max Walters, January 08 2026

Patents

The inside man: law firm partner praises China’s IP value

Chunguang Hu of China PAT explains why his ‘insider’ experience as a patent examiner benefits clients and why he wants to debunk the myth that IP has limited value in China

January 08 2026

Patents

‘Boutique with more fuel in the tank’: Obhan Mason head on merger

Essenese Obhan shares his expansion plans and vision of creating a ‘one-stop shop’ for clients after Indian firms Obhan & Associates and Mason & Associates joined forces

Sukanya Sarkar, January 07 2026

Global influence of China depicted by an earth globe with the Chinese flag amidst a powerful, transformative atmosphere with fog. Rotation of the planet.

The year ahead: China eyes ‘problematic’ TMs and Europe’s FRAND predicament

From AI and the UPC to troublesome trademarks in China, experts name the IP trends likely to dominate 2026

January 07 2026

Patents

Goodwin hires prosecution expert from Cooley

Colm Murphy says he is keen to help clients navigate cross-border IP challenges in Europe

January 06 2026

Patents

happy new year, new year's eve, silvester, new years eve, sparklers celebration greeting card, new year card - Year 2026 in sparkler font and firework fireworks pyrotechnic, blue night sky background

Pro-patent policies and AI replicas: 2026 predictions

With 2025 behind us, US practitioners sit down with Managing IP to discuss the major IP moments from the year and what to expect in 2026

Sanjana Mishra, January 05 2026

Patents

Europe at night with glowing city lights, seen from space

Weekly take: Will 2026 see the wind of change come to Europe?

Large-scale transatlantic mergers will give US entities a strong foothold at the UPC, and could spark further fragmentation of European patent practices

Max Walters, January 05 2026